The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Exiger warns the U.S. is overly reliant on foreign countries to make key components of crucial medications as the Trump ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

Piramal Pharma Limited (PPL) is a leading pharmaceutical company and part of the Piramal Group. The company was established ...

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

Divi's Labs said it will invest Rs 650-700 crore in capacity expansion and that it eyes significant revenue boost ...

Mid-sized Indian pharma firms revamp strategies amid US tariff concerns, focusing on NCDs, API manufacturing, emerging ...

Donald Trump announced a forthcoming "major" tariff on pharmaceutical imports, aiming to incentivize drug companies to ...